Voleon Capital Management’s DexCom DXCM Stock Holding History

Voleon Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$33M	Sell	525,617 -11,655	-2%	-$812K	0.71%	22
2025 Q4	$35.7M	Buy	537,272 +284,954	+113%	+$18.4M	0.77%	15
2025 Q3	$17M	Buy	252,318 +184,509	+272%	+$14.6M	0.41%	39
2025 Q2	$5.92M	Sell	67,809 -9,301	-12%	-$729K	0.32%	74
2025 Q1	$5.27M	Buy	77,110 +19,188	+33%	+$1.57M	0.41%	65
2024 Q4	$4.5M	Buy	+57,922	New	+$4.29M	0.33%	79
2019 Q3	–	Sell	-32,000	Closed	-$1.2M	–	173
2019 Q2	$1.2M	Buy	+32,000	New	+$1.01M	0.07%	155

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Voleon Capital Management's DXCM Position: Q1 2026 in Review

Voleon Capital Management reduced its DexCom (DXCM) stake by 2.2% in Q1 2026, selling an estimated $812K and leaving 525,617 shares worth $33M. The position accounts for 0.71% of the portfolio, ranked #22.

Voleon Capital Management first reported a position in DXCM in Q2 2019 and has held it in 7 quarters since. The position peaked at $35.7M in Q4 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Voleon Capital Management held 525,617 shares of DexCom worth $33M as of Q1 2026.
Voleon Capital Management sold 11,655 DexCom shares in Q1 2026, an estimated $812K.
DexCom made up 0.71% of Voleon Capital Management's portfolio in Q1 2026, its #22 holding.
Voleon Capital Management first reported a position in DexCom in Q2 2019 and has held it in 7 quarters since.
Voleon Capital Management's DexCom position peaked at $35.7M in Q4 2025.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.